Recent Finacing
Recent Raise
Sironax is a Beijing-based clinical-stage biotechnology company developing RIPK1 inhibitors and programs targeting regulated cell death, neuroprotection, and neuroinflammation for age-related degenerative diseases, with early clinical and preclinical work.
